{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:06:34Z","timestamp":1750824394754,"version":"3.41.0"},"reference-count":74,"publisher":"Jaypee Brothers Medical Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.59556\/japi.73.0782","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T07:14:13Z","timestamp":1750749253000},"page":"49-57","source":"Crossref","is-referenced-by-count":0,"title":["A Concise Review on Different Aspects of Influences of Coronavirus Disease 2019 on Liver and Metabolic Changes"],"prefix":"10.59556","volume":"73","author":[{"given":"Rajdeep","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi C","family":"Yarlagadda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaitali","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tejashwi","family":"Paruchuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debasish","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaheli","family":"Rudra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gargi","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"issue":"(23):","key":"key20250624071408_B1","doi-asserted-by":"crossref","first-page":"2255\u2013","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm.","volume":"383","author":"Fajgenbaum","year":"2020;","journal-title":"New Engl J Med"},{"issue":"(9):","key":"key20250624071408_B2","doi-asserted-by":"crossref","first-page":"1152\u2013","DOI":"10.1001\/jamainternmed.2020.3313","article-title":"Is a \u201ccytokine storm\u201d relevant to COVID-19?","volume":"180","author":"Sinha","year":"2020;","journal-title":"JAMA Intern Med"},{"key":"key20250624071408_B3","doi-asserted-by":"crossref","DOI":"10.1002\/hep4.1745","article-title":"Impact of COVID-19 in liver disease progression.","author":"Martinez MA","year":"2021.","journal-title":"Hepatol Commun"},{"issue":"(10223):","key":"key20250624071408_B4","doi-asserted-by":"crossref","first-page":"497\u2013","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"395","author":"Huang","year":"2020;","journal-title":"Lancet"},{"key":"key20250624071408_B5","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival.","author":"Wang","year":"2020.","journal-title":"Nat Med"},{"issue":"(6):","key":"key20250624071408_B6","doi-asserted-by":"crossref","first-page":"1385\u2013","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance.","volume":"61","author":"Albillos","year":"2014;","journal-title":"J Hepatol"},{"key":"key20250624071408_B7","doi-asserted-by":"crossref","first-page":"567\u2013","DOI":"10.1016\/j.jhep.2020.09.024","article-title":"Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study.","volume":"74:","author":"Marjot","year":"2020;","journal-title":"J Hepatol"},{"issue":"(10):","key":"key20250624071408_B8","doi-asserted-by":"crossref","first-page":"929\u2013","DOI":"10.1056\/NEJMoa1406761","article-title":"Clinical features and outcomes of Takotsubo (stress) cardiomyopathy.","volume":"373","author":"Templin","year":"2015;","journal-title":"New Engl J Med"},{"issue":"(26):","key":"key20250624071408_B9","doi-asserted-by":"crossref","first-page":"7996\u2013","DOI":"10.1073\/pnas.1509123112","article-title":"Ras-GTP dimers activate the mitogen-activated protein kinase (MAPK) pathway.","volume":"112","author":"Nan","year":"2015;","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"(1):","key":"key20250624071408_B10","doi-asserted-by":"crossref","first-page":"17\u2013","DOI":"10.1016\/j.cell.2017.06.009","article-title":"RAS proteins and their regulators in human disease.","volume":"170","author":"Simanshu","year":"2017;","journal-title":"Cell"},{"key":"key20250624071408_B11","doi-asserted-by":"crossref","first-page":"651658.","DOI":"10.3389\/fmed.2021.651658","article-title":"Potential effects of coronaviruses on the liver: an update.","volume":"8:","author":"Wang","year":"2021;","journal-title":"Front Med (Lausanne)"},{"issue":"(3):","key":"key20250624071408_B12","doi-asserted-by":"crossref","first-page":"387\u2013","DOI":"10.1016\/j.jhep.2007.03.008","article-title":"Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis.","volume":"47","author":"Herath","year":"2007;","journal-title":"J Hepatol"},{"issue":"(12):","key":"key20250624071408_B13","doi-asserted-by":"crossref","first-page":"1790\u2013","DOI":"10.1136\/gut.2004.062398","article-title":"Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2.","volume":"54","author":"Paizis","year":"2005;","journal-title":"Gut"},{"issue":"(4):","key":"key20250624071408_B14","doi-asserted-by":"crossref","first-page":"473\u2013","DOI":"10.1007\/s10238-018-0519-0","article-title":"Dipeptidyl peptidase-4 (DPP-4) inhibitors: promising new agents for autoimmune diabetes.","volume":"18","author":"Wang","year":"2018;","journal-title":"Clin Exp Med"},{"issue":"(12).","key":"key20250624071408_B15","article-title":"Multi-organ damage in human dipeptidyl peptidase 4 transgenic mice infected with Middle East respiratory syndrome-coronavirus.","volume":"10","author":"Zhao","year":"2015;","journal-title":"PLoS One"},{"issue":"(11):","key":"key20250624071408_B16","first-page":"712\u2013","article-title":"Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4.","volume":"212","author":"K","year":"2016;","journal-title":"J Infect Dis"},{"issue":"(6).","key":"key20250624071408_B17","article-title":"Clinical and immune features of hospitalized pediatric patients with coronavirus disease 2019 (COVID-19) in Wuhan, China.","volume":"3","author":"Wu","year":"2020;","journal-title":"JAMA Netw Open"},{"issue":"(5):","key":"key20250624071408_B18","doi-asserted-by":"crossref","first-page":"1451\u2013","DOI":"10.1038\/s41418-020-0530-3","article-title":"COVID-19 infection: the perspectives on immune responses.","volume":"27","author":"Shi","year":"2020;","journal-title":"Cell Death Differ"},{"issue":"(11):","key":"key20250624071408_B19","doi-asserted-by":"crossref","first-page":"1619\u2013","DOI":"10.1016\/j.jiph.2020.07.001","article-title":"Immune response in COVID-19: a review.","volume":"13","author":"Chowdhury","year":"2020;","journal-title":"J Infect Public Health"},{"key":"key20250624071408_B20","doi-asserted-by":"crossref","first-page":"25\u2013","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system.","volume":"53:","author":"Coperchini","year":"2020;","journal-title":"Cytokine Growth Factor Rev"},{"issue":"(8):","key":"key20250624071408_B21","first-page":"493\u2013","article-title":"Clinical characteristics and mechanism of liver injury in patients with severe acute respiratory syndrome.","volume":"11","author":"Duan","year":"2003;","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"key20250624071408_B22","doi-asserted-by":"crossref","first-page":"104370.","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.","volume":"127:","author":"Liu","year":"2020;","journal-title":"J Clin Virol"},{"key":"key20250624071408_B23","doi-asserted-by":"crossref","first-page":"102473.","DOI":"10.1016\/j.jaut.2020.102473","article-title":"Characteristics and prognostic factors of disease severity in patients with COVID-19: the Beijing experience.","volume":"112:","author":"Sun","year":"2020;","journal-title":"J Autoimmun"},{"key":"key20250624071408_B24","doi-asserted-by":"crossref","first-page":"475\u2013","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China.","volume":"8:","author":"Yang","year":"2020;","journal-title":"Lancet Respir Med"},{"key":"key20250624071408_B25","doi-asserted-by":"crossref","first-page":"181\u2013","DOI":"10.1007\/978-3-540-93842-2_15","article-title":"Hypoxic liver injury.","author":"Dancygier","year":"2010.","journal-title":"Clinical Hepatology: Principles and Practice of Hepatobiliary Diseases"},{"issue":"(6):","key":"key20250624071408_B26","doi-asserted-by":"crossref","first-page":"1138\u2013","DOI":"10.1016\/j.mayocp.2020.04.006","article-title":"Association between hypoxemia and mortality in patients with COVID-19.","volume":"95","author":"Xie","year":"2020;","journal-title":"Mayo Clin Proc"},{"issue":"(7).","key":"key20250624071408_B27","article-title":"COVID-19 med stille hypoksemi.","volume":"140","author":"Ottestad","year":"2020;","journal-title":"Tidsskrift for Den norske legeforening"},{"issue":"(11):","key":"key20250624071408_B28","doi-asserted-by":"crossref","first-page":"1303\u2013","DOI":"10.1002\/lt.22157","article-title":"Reactive oxygen species mediate human hepatocyte injury during hypoxia\/reoxygenation.","volume":"16","author":"Bhogal","year":"2010;","journal-title":"Liver Transpl"},{"issue":"(14):","key":"key20250624071408_B29","doi-asserted-by":"crossref","first-page":"1063\u2013","DOI":"10.2169\/internalmedicine.46.0059","article-title":"Hypoxic hepatopathy: pathophysiology and prognosis.","volume":"46","author":"Birrer","year":"2007;","journal-title":"Intern Med"},{"key":"key20250624071408_B30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104362","article-title":"Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past.","volume":"127.","author":"Giannis","year":"2020;","journal-title":"J Clin Virol"},{"issue":"(6):","key":"key20250624071408_B31","doi-asserted-by":"crossref","first-page":"1089\u2013","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.","volume":"46","author":"Helms","year":"2020;","journal-title":"Intensive Care Med"},{"issue":"(10):","key":"key20250624071408_B32","doi-asserted-by":"crossref","first-page":"2448\u2013","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.06.017","article-title":"Increased serum alkaline phosphatase as a predictor of symptomatic hemorrhagic transformation in ischemic stroke patients with atrial fibrillation and\/or rheumatic heart disease.","volume":"25","author":"Liu","year":"2016;","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"(6):","key":"key20250624071408_B33","doi-asserted-by":"crossref","first-page":"826\u2013","DOI":"10.7326\/0003-4819-104-6-826","article-title":"Drug-induced hepatotoxicity.","volume":"104","author":"Kaplowitz","year":"1986;","journal-title":"Ann Intern Med"},{"key":"key20250624071408_B34","doi-asserted-by":"crossref","first-page":"73\u2013","DOI":"10.1016\/j.phymed.2018.09.174","article-title":"A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins.","volume":"50:","author":"Li","year":"2018;","journal-title":"Phytomedicine"},{"issue":"(1):","key":"key20250624071408_B35","first-page":"1\u2013","article-title":"A review on antimalarial drug.","volume":"1","author":"Kumar Sharma","year":"2015;","journal-title":"Int J Basic Clin Pharmacol"},{"issue":"(1):","key":"key20250624071408_B36","doi-asserted-by":"crossref","first-page":"115\u2013","DOI":"10.1016\/j.cld.2016.08.009","article-title":"Drug hepatotoxicity: newer agents.","volume":"21","author":"Bunchorntavakul","year":"2017;","journal-title":"Clin Liver Dis"},{"issue":"(9):","key":"key20250624071408_B37","first-page":"1525\u2013","article-title":"SARS: systematic review of treatment effects.","volume":"3","author":"Stockman","year":"2006;","journal-title":"PLoS Med"},{"issue":"(6):","key":"key20250624071408_B38","doi-asserted-by":"crossref","first-page":"1364\u2013","DOI":"10.1002\/hep.20948","article-title":"Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.","volume":"42","author":"Larson","year":"2005;","journal-title":"Hepatology"},{"key":"key20250624071408_B39","doi-asserted-by":"crossref","first-page":"245\u2013","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"5:","author":"Sepanlou","year":"2020;","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"(1):","key":"key20250624071408_B40","doi-asserted-by":"crossref","first-page":"151\u2013","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world.","volume":"70","author":"Asrani","year":"2019;","journal-title":"J Hepatol"},{"issue":"(1):","key":"key20250624071408_B41","doi-asserted-by":"crossref","first-page":"54\u2013","DOI":"10.1055\/s-0029-1245947","article-title":"The liver as an immunological organ.","volume":"49","author":"Benseler","year":"2011;","journal-title":"Z Gastroenterol"},{"key":"key20250624071408_B42","doi-asserted-by":"crossref","first-page":"1008\u2013","DOI":"10.1016\/S2468-1253(20)30271-5","article-title":"Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.","volume":"5:","author":"Webb","year":"2020;","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"(1):","key":"key20250624071408_B43","doi-asserted-by":"crossref","first-page":"4\u2013","DOI":"10.1111\/jvh.13440","article-title":"SARS-CoV-2 infection in patients with a normal or abnormal liver.","volume":"28","author":"Cabibbo","year":"2021;","journal-title":"J Viral Hepat"},{"issue":"(5):","key":"key20250624071408_B44","first-page":"267\u2013","article-title":"Study on the damage of liver in patients with SARS.","volume":"16","author":"Guan","year":"2004;","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"(4):","key":"key20250624071408_B45","doi-asserted-by":"crossref","first-page":"2243\u2013","DOI":"10.1002\/jmv.26656","article-title":"Non-severe immunosuppression might be associated with a lower risk of moderate\u2013severe acute respiratory distress syndrome in COVID-19: a pilot study.","volume":"93","author":"Monreal","year":"2021;","journal-title":"J Med Virol"},{"issue":"(1):","key":"key20250624071408_B46","doi-asserted-by":"crossref","first-page":"5\u2013","DOI":"10.1016\/j.amjms.2020.05.006","article-title":"A comprehensive review of manifestations of novel coronaviruses in the context of deadly COVID-19 global pandemic.","volume":"360","author":"Gulati","year":"2020;","journal-title":"Am J Med Sci"},{"issue":"(3):","key":"key20250624071408_B47","first-page":"229\u2013","article-title":"Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area.","volume":"28","author":"Qian","year":"2020;","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"(12):","key":"key20250624071408_B48","doi-asserted-by":"crossref","first-page":"1504\u2013","DOI":"10.1111\/jvh.13362","article-title":"Clinical characteristics in patients with SARS-CoV-2\/HBV co-infection.","volume":"27","author":"Chen","year":"2020;","journal-title":"J Viral Hepat"},{"issue":"(1):","key":"key20250624071408_B49","doi-asserted-by":"crossref","first-page":"80\u2013","DOI":"10.1111\/jvh.13404","article-title":"Epidemiological and clinical characteristics of 70 cases of coronavirus disease and concomitant hepatitis B virus infection: a multicentre descriptive study.","volume":"28","author":"Wu","year":"2021;","journal-title":"J Viral Hepat"},{"issue":"(11):","key":"key20250624071408_B50","doi-asserted-by":"crossref","first-page":"1211\u2013","DOI":"10.1111\/hepr.13553","article-title":"Longitudinal changes of liver function and hepatitis B reactivation in COVID-19 patients with pre-existing chronic hepatitis B virus infection.","volume":"50","author":"Liu","year":"2020;","journal-title":"Hepatol Res"},{"issue":"(1):","key":"key20250624071408_B51","doi-asserted-by":"crossref","first-page":"234\u2013","DOI":"10.1016\/j.jhep.2015.07.041","article-title":"Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use.","volume":"64","author":"Dyson","year":"2016;","journal-title":"J Hepatol"},{"key":"key20250624071408_B52","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.8645","article-title":"COVID-19 induced hepatitis B virus reactivation: a novel case from the United Arab Emirates.","author":"Aldhaleei","year":"2020.","journal-title":"Cureus"},{"issue":"(8):","key":"key20250624071408_B53","doi-asserted-by":"crossref","first-page":"765\u2013","DOI":"10.1016\/S2468-1253(20)30182-5","article-title":"Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective.","volume":"5","author":"Barry","year":"2020;","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"(6):","key":"key20250624071408_B54","doi-asserted-by":"crossref","first-page":"595\u2013","DOI":"10.1016\/j.dld.2020.03.030","article-title":"COVID-19 and cancer patients: choosing wisely is the key.","volume":"52","author":"Cannizzaro","year":"2020;","journal-title":"Dig Liver Dis"},{"issue":"(5):","key":"key20250624071408_B55","doi-asserted-by":"crossref","first-page":"53.","DOI":"10.1007\/s11912-020-00934-7","article-title":"COVID-19 and cancer: a comprehensive review.","volume":"22","author":"Gosain","year":"2020;","journal-title":"Curr Oncol Rep"},{"issue":"(8):","key":"key20250624071408_B56","doi-asserted-by":"crossref","first-page":"1128\u2013","DOI":"10.1016\/j.hpb.2020.05.012","article-title":"Delivery of hepato-pancreato-biliary surgery during the COVID-19 pandemic: an European-African Hepato-Pancreato-Biliary Association (E-AHPBA) cross-sectional survey.","volume":"22","author":"Balakrishnan","year":"2020;","journal-title":"HPB"},{"key":"key20250624071408_B57","doi-asserted-by":"crossref","first-page":"687484.","DOI":"10.1155\/2015\/687484","article-title":"Semiannual imaging surveillance is associated with better survival in patients with non-B, non-C hepatocellular carcinoma.","volume":"2015:","author":"Shindo","year":"2015;","journal-title":"Mediators Inflamm"},{"issue":"(13):","key":"key20250624071408_B58","doi-asserted-by":"crossref","first-page":"1550\u2013","DOI":"10.3748\/wjg.v25.i13.1550","article-title":"Hepatocellular carcinoma surveillance: an evidence-based approach.","volume":"25","author":"Harris","year":"2019;","journal-title":"World J Gastroenterol"},{"key":"key20250624071408_B59","article-title":"Implication of non-alcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis implication of non-alcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis.","author":"Ji","year":"2020.","journal-title":"J Hepatol"},{"issue":"(4):","key":"key20250624071408_B60","doi-asserted-by":"crossref","first-page":"733\u2013","DOI":"10.1136\/gutjnl-2020-321726","article-title":"Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19.","volume":"70","author":"Yip","year":"2021;","journal-title":"Gut"},{"issue":"(9).","key":"key20250624071408_B61","article-title":"Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: a federated electronic medical record analysis.","volume":"17","author":"Harrison","year":"2020;","journal-title":"PLoS Med"},{"issue":"(2):","key":"key20250624071408_B62","doi-asserted-by":"crossref","first-page":"768\u2013","DOI":"10.1053\/j.gastro.2020.04.064","article-title":"Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: a multicenter research network study.","volume":"159","author":"Singh","year":"2020;","journal-title":"Gastroenterology"},{"key":"key20250624071408_B63","doi-asserted-by":"crossref","first-page":"451\u2013","DOI":"10.1016\/j.jhep.2020.03.044","article-title":"Non-alcoholic fatty liver diseases in patients with COVID- 19: a retrospective study.","volume":"73:","author":"Ji","year":"2020;","journal-title":"J Hepatol"},{"issue":"(8):","key":"key20250624071408_B64","doi-asserted-by":"crossref","first-page":"1545\u2013","DOI":"10.1136\/gutjnl-2020-321611","article-title":"Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.","volume":"69","author":"Targher","year":"2020;","journal-title":"Gut"},{"key":"key20250624071408_B65","doi-asserted-by":"crossref","DOI":"10.1097\/MEG.0000000000002048","article-title":"The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.","author":"Davidov-Derevynko","year":"2021.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"(11):","key":"key20250624071408_B66","doi-asserted-by":"crossref","first-page":"1794\u2013","DOI":"10.1093\/infdis\/jiaa550","article-title":"The fibrosis-4 index is associated with need for mechanical ventilation and 30-day mortality in patients admitted with coronavirus disease 2019.","volume":"222","author":"Sterling","year":"2020;","journal-title":"J Infect Dis"},{"issue":"(3):","key":"key20250624071408_B67","doi-asserted-by":"crossref","first-page":"748\u2013","DOI":"10.1016\/j.jhep.2020.12.007","article-title":"Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD.","volume":"74","author":"Meijnikman","year":"2021;","journal-title":"J Hepatol"},{"issue":"(3):","key":"key20250624071408_B68","doi-asserted-by":"crossref","first-page":"717\u2013","DOI":"10.1016\/j.jhep.2020.04.035","article-title":"No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease.","volume":"73","author":"Biquard","year":"2020;","journal-title":"J Hepatol"},{"key":"key20250624071408_B69","doi-asserted-by":"crossref","first-page":"100688.","DOI":"10.1016\/j.eclinm.2020.100688","article-title":"COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States.","volume":"31:","author":"Wang","year":"2021;","journal-title":"EClinicalMedicine"},{"issue":"(3):","key":"key20250624071408_B70","doi-asserted-by":"crossref","first-page":"1102\u2013","DOI":"10.1002\/hep.31307","article-title":"Coronavirus disease 2019 hangover: a rising tide of alcohol use disorder and alcohol-associated liver disease.","volume":"72","author":"Da","year":"2020;","journal-title":"Hepatology"},{"key":"key20250624071408_B71","doi-asserted-by":"crossref","first-page":"566\u2013","DOI":"10.1016\/j.jhep.2020.04.006","article-title":"COVID-19: abnormal liver function tests.","volume":"73:","author":"Cai","year":"2020;","journal-title":"J Hepatol"},{"issue":"(12):","key":"key20250624071408_B72","doi-asserted-by":"crossref","first-page":"2835\u2013","DOI":"10.1016\/j.cgh.2020.07.050","article-title":"Hepatic disorders with the use of remdesivir for coronavirus 2019.","volume":"18","author":"Montastruc","year":"2020;","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"(7850):","key":"key20250624071408_B73","doi-asserted-by":"crossref","first-page":"451\u2013","DOI":"10.1038\/s41586-021-03312-w","article-title":"SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.","volume":"591","author":"Wahl","year":"2021;","journal-title":"Nature"},{"issue":"(6):","key":"key20250624071408_B74","doi-asserted-by":"crossref","first-page":"102514.","DOI":"10.1016\/j.dsx.2022.102514","article-title":"Drug-induced diabetes and hepatoxicity in COVID-19 patients.","volume":"16","author":"Ghosh","year":"2022;","journal-title":"Diabetes Metab Syndr"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T07:14:23Z","timestamp":1750749263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-73-1-49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.59556\/japi.73.0782"],"URL":"https:\/\/doi.org\/10.59556\/japi.73.0782","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}